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 Debilitating anxiety affects 6.8 million Americans. Cortisol is an established measure of 
the stress response which reflects the hypothalamic-pituitary-adrenal (HPA) axis activity.  
However, salivary alpha-amylase (sAA) is a relatively new measure of the stress response, and it 
reflects the sympathetic-adrenal-medullary pathway (SAM pathway) activity. Our aim was to 
compare these two aspects of the stress response in a Generalized Anxiety Disorder (GAD) and a 
non-clinical population under a stressful stimulus (Knee replacement surgery video). To our 
knowledge this is the first time anyone has looked at both sAA and cortisol together with respect 
to GAD. We hypothesized that both cortisol and sAA levels would raise from pre-stimulus to 
post-stimulus, but not in concert. Forty-six college students were assessed for GADs and 
randomly assigned to watch a stressful or neutral video. Saliva samples were taken at the 
beginning of the study, immediately after the video, and 30 minutes after the video. Participants 
were also given the Taylor Manifest Anxiety Scale TMAS and Beck Anxiety Inventory BAI as 
measures of state and trait anxiety. There was a significant difference between GAD and non-
clinical groups for the TMAS and a significant group by condition interaction for baseline 
cortisol. Our GAD, stress sub-group had a significantly raised baseline cortisol level. Although 
the GAD and Non-clinical groups did not differ significantly with regard to baseline cortisol 
levels, it was in the hypothesized direction.  Moreover, baseline cortisol levels were inversely 
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Section 1: Introduction 
 According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, 1994), 
anxiety disorders include panic disorder, agoraphobia, post-traumatic stress disorder (PTSD), 
obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), and generalized 
anxiety disorder (GAD). Estimates indicate that 6.8 million Americans exhibit debilitating 
anxiety (Kessler, Chiu, Demler, Walters, 2005). The common feature within anxiety disorders is 
excessive, irrational fear and avoidance of anxiety triggers. The impact of pathological anxiety 
extends to impaired workplace performance, hefty economic costs of up to 40 billion dollars 
each year (Greenberg, Sisitsky, Kessler,  Finkelstein, Berndt, Davidson, 1999), greater risk of 
cardiovascular and cerebral vascular disease (Vogelzangs, Seldenrijk, Beekman, de Jonge, 
Penninx, 2010), and associations with mild cognitive impairment (Devier, Pelton, Tabert, Liu, 
Cuasay, Stern, Devanand, 2009).  Thus, knowledge pertaining to this construct is impactful in a 
multitude of ways. 
 Anxiety has been conceptualized in many ways, consisting of several domains, making it 
a difficult topic to easily summarize or explain. According to Speilberger (1966), there are two 
forms of anxiety. The first form is state anxiety, which reflects a transitory emotional state or a 
condition that is characterized by subjective, consciously perceived feelings of tension and 
apprehension, and heightened autonomic nervous system activity. State anxiety is a variable state 
and may fluctuate. The second form is trait anxiety which refers to a general tendency to respond 
with anxiety to perceived threats in the environment, and it is a relatively stable characteristic of 
an individual. An individual with higher trait anxiety feels more threats in many situations than 
someone with low trait anxiety (Horikawa & Yagi, 2012).  
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Recent research has also categorized anxiety with fear as a physiological threat response. 
Fear is a phasic response to an immediate threat and anxiety is a prolonged worrisome state to 
some future threat (Walker, Toufexis, Davis, 2003). Barlow & Lehman, (1996) described anxiety 
as a future-oriented cognitive-affective-somatic state; the prominent feature being ‘‘a sense of 
uncontrollability focused on possible future threat, danger, or other upcoming, potentially 
negative events.’’ Paulus, Feinstein, Simmons, & Stein, (2004) propose anxiety as a 
manifestation of cognitions related to the self. What unites these theories is that in one way or 
another anxiety elicits a physical stress response. 
 Anxiety is the body’s natural reaction to real or perceived danger. The body then goes 
through a series of chemical and physical changes, called stress responses, to prepare for the 
danger. There are two stress responses in the body. When the body is presented with an 
immediate threat or danger, the sympathetic-adrenal-medullary pathway (SAM) is activated. 
This sympathetic nervous system pathway starts with biosynthesis in the adrenal medulla and 
releases several catacholomines including epinephrine, norepinephrine, and dopamine. This is 
commonly referred to as the fight or flight response. The second stress response pathway is the 
slower moving hypothalamic-pituitary-adrenal (HPA) axis. When a threat or danger is perceived, 
corticotrophin releasing factor (CRF) is produced in the hypothalamus and sent to the anterior 
pituitary gland in the brain. The pituitary gland then produces adrenocorticotropic hormone 
(ACTH ) which is sent to the adrenal cortex where biosynthesis in the adrenal cortex produces 
the hormone cortisol. It allows the body to prolong the fight or flight response.  
We aim to investigate possible differences between the two stress response systems in a 
GAD sample compared to a control sample. Throughout this thesis, we will review state vs. trait 
anxiety, several theories surrounding the concept of anxiety, and the endocrinology links to 
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stress. In the current study we will examine the neuroendocrinology of anxiety in a GAD 
populations compared to a normal population using salivary cortisol to test the response of the 
HPA axis and alpha amylase (sAA) to measure the (SAM) system under a stressful stimulus.  
Trait v. State Anxiety  
 State and trait anxiety are commonly accepted as separate forms of anxiety. State and trait 
anxiety are distinctive in that state anxiety is classified as a temporary state of worry and trait 
anxiety is an enduring predisposition to anxiety that is consistent across situations (Spielberger, 
1985). Trait and state anxiety have both been proposed to be uni-dimensional, bimodal, and 
multidimensional constructs (Davidson & Schwartz, 1976; Everitt, 1981; Spielberger, 1985). The 
uni-dimensional view is the separation of trait and state as single entities with state anxiety being 
the actual physical arousal to a stimulus and trait being the predisposition for arousal 
(Spielberger, 1985). The multidimensional view breaks state anxiety into possessing somatic and 
cognitive components (Davidson & Schwartz, 1976) and trait anxiety into social, ambiguous, 
danger, and daily routine components (Endler & Kocovski, 2001).   
 Trait anxiety comprises the tendency to respond anxiously to a wide variety of unspecific 
stressors (Spielberger, 1972). Interestingly, Wilkin, Smith, Tola, Mann, (2000) reported that low 
trait anxious subjects showed a greater stress response than high trait subjects. The authors 
explained this in several ways. First, the high trait anxious group could have higher baselines of 
physiological stress; thus, the presentation of the stimulus pushed them over the inverted “U” 
arousal curve. The authors further explained, low trait anxious individual showed a linear trend 
of arousal up one side of the inverted “U”. In addition, trait anxiety has been shown to be highly 
consistent with cognitive and somatic state anxiety ratings (Gould, Petlichkoff, Weinberg, 1984; 
Hanton, Mellalieu, Hall, 2002). Additionally, trait anxiety and subjective autonomic response 
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reports have shown a positive correlation with basal cortisol levels but not cortisol elevation to a 
social stress test in 20 healthy young men (Takahashi, Ikeda, Ishikawa, Kitamura, Tsukasaki, 
Nakama, Kameda, 2005). 
 Neurophysiologically, healthy subjects who scored high on trait anxiety have smaller 
prefrontal cortical volume (Spampinato, Wood, De Simone, Grafman, 2009) and less 
connectivity between the prefrontal cortex and the amygdala (Kim & Whalen, 2009). Paulus, 
Feinstein, Simmons, & Stein, (2004) however, found that activation of the anterior cingulated 
cortex and medial prefrontal cortex were significantly higher in high trait-anxiety subjects and 
was correlated with trait but not state anxiety. The prefrontal cortex has been shown to inhibit the 
HPA axis (Jahn, Fox, Abercrombie, Shelton, Oakes, Davidson, Kalin, 2010), and therefore may 
play a role in the dysfunction of the chemical stress response related to anxiety. Dysfunctions in 
the chemical stress response have been reported to correlate with generalized anxiety disorder. 
For example, Elevated cortisol levels have also been found in children ages 8 - 13 with anxiety 
disorders (McBurnett, Lahey, Frick, Risch, Loeber, Hart, Hanson, 1991) and older adults with 
GAD (Mantella, Butters, Amico, Mazumdar, Rollman, Begley, Reynolds, Lenze, 2008). 
 It is unclear in the literature how the HPA axis and SAM pathway work with respect to 
state or trait anxiety. However, this study will provide data in which to start differentiating 
between normal and pathological anxiety in relation to the HPA axis and SAM pathway.   
Theories of Anxiety  
Barlow’s Anxious Apprehension Model 
 David Barlow proposed a bidirectional model of arousal and attention. He posits that 
negative affect causes a shift in attention to self-evaluative focus, which results in further 
increases of arousal and narrows attention to potential threats. This creates a constant state of 
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worry characterized by avoidance behaviors. He suggests that people tend to explain their 
arousal in terms of their negative view of the world. So as arousal rises, the more negative the 
world appears creating a negative feedback loop (Barlow, 1988). 
Eysenck’s Interversion/Extroversion 
 Eysenck proposed arousal on a continuum with introversion and extroversion at the polar 
ends. He argues that introverts are already highly aroused and aim to maintain or lower there 
arousal via avoidance of social situations. Extroverts are low in arousal and aim to increase their 
arousal level by seeking social stimulation. Eysenck proposes introversion and extraversion are 
located on a theoretical horizontal axis. In addition, a theoretical vertical axis contains 
neuroticism and stability at its polar ends. Neurotic individuals would be characterized by high 
autonomic function, while stable individuals would be characterized by low autonomic function 
(Eysenck, 1967). Grey (1982) then proposed an additional axis running from the 
introversion/neuroticism quartile through to the extroversion/stability quartile, which indicates 
types of symptomatic behavior. He believes, if an individual is too far in the introvert/neurotic 
quartile this leads to anxiety and too far in the extravert/stable quartile leads to impulsive 
behavior.  
Aversive Conditioning 
Recent research has focused on the aversive conditioning of an intertwined anxiety/fear 
network. In aversive conditioning, fear is described as a phasic response to imminent threat 
(Walker et al. 2003) typified by a surge of physiological arousal as in an alarm reaction 
(flight/fight) of the autonomic nervous system (Blanchard Sakai, McEwen, Weiss, Blanchard, 
1993).  Alternatively, anxiety is a sustained response to temporarily uncertain danger (Walker et 
al., 2003), which may be distal and distinguished via heightened apprehension and vigilance 
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(Blanchard et al., 1993).  Behaviorally, anxiety is associated with avoidance and increased 
overall sensory sensitivity (Baas, Nugent, Lissek, Pine, Grillon, 2004; Cornwell, Baas, Johnson, 
Holroyd, Carver, Lissek, Grillion, 2007) commonly derived from aversive conditioning.   
 Aversive conditioning occurs when a discrete, conditioned stimulus (CS), such as a light, 
is paired with an aversive unconditioned stimulus (e.g., a shock). Fear will develop to the 
discrete cue and to the environmental context (LeDoux, 1996). For example, the repeated pairing 
of a rabbit with an electric shock may cause the rabbit to become an aversive stimulus for that 
individual.  
Eventually, this notion led to an unfolding of several other theories. The Preparedness 
Theory (Seligman, 1971) results from Pavlovian conditioning, but postulates that some stimuli 
are naturally dispositioned for aversive conditioning. These neutral stimuli are graded along a 
continuum of biological predispositions for a fear condition. These predispositions extend from a 
pre-technological age that may include commonly feared stimuli such as snakes or spiders. 
Within this theory, these commonly feared stimuli should be conditioned more rapidly, be more 
resistant to extinction, and be more resistant to cognitive influences.  The alternative to the 
Preparedness Theory is Equipotentiality Hypothesis, which assumes that all stimuli have equal 
potential to be fear eliciting. The equipotentiality theory was confirmed by McNally & Reiss 
(1982) when they used both snakes and flowers as unconditioned stimuli. They found that both 
predispositioned stimuli, such as a snake, and neutral stimuli, such as a flower, have potential for 
aversive conditioning. 
Multi-Network Dysfunction  
 Sylvester, Corbetta, Raichle, Rodebaugh, Schlagger, Sheline, Zorumski, Lenze, (2012) 
reject the notion of a single circuit, such as the fear/anxiety circuit. Contrarily, they propose an 
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individual’s fear or anxiety behavior may be the product of several dysregulated circuits.  This 
theory is based on the idea that the study of functional networks will revolutionize our 
perspectives of psychological disorders.  Findings suggest that psychological disorders may 
merely be disruptions in differential combinations of networks. Their research reveals for 
anxiety, dysregulation lies in the overactive cingulo-opercular and ventral attention network and 
underactive default mode in the frontal parietal network. The cingulo-operular network includes 
the dorsal AC, anterior thalamus, anterior PFC and the insula; it is important for cognitive 
control of error and conflict detection (Sylvester et al., 2012). Over activity in this network may 
establish rumination involving errors or conflict.  The ventral attention system includes the 
ventrolateral PFC and temporal parietal junction and is involved in directing attention to newly 
appearing stimuli (Sylvester et al., 2012). Excessive activity of this network may cause an 
individual to focus on unnecessary stimuli.  
Anxiety Sensitivity 
The anxiety sensitivity construct has a similar concept to trait anxiety, with the 
distinguishing feature being “fear of fear” (Reiss & McNally, 1985). It is described as “an 
individual difference variable consisting of beliefs about the experience of anxiety/fear which 
causes illness, embarrassment or additional anxiety.”  For example, when the doctor tells an 
individual to avoid excitement in order to minimize the risk of a heart attack, the advice should 
increase the patients’ motivation to avoid exciting stimuli. However, this advice increases the 
patients anxiety without experiencing a heart attack themselves. In fact, one criterion for panic 
disorder is fear of having another panic attack (DSM-IV, 1994). This possibly contributes further 
to anxiety disorders. It has been shown that anxiety sensitivity, as measured by the Anxiety 
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Sensitivity Index (ASI), is higher in patients with anxiety disorders and extremely higher in 
individuals with agoraphobia (Reiss and McNally, 1986).  
Attentional Control Theory 
A meta-analysis by Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, van IJzendoorn 
(2007) demonstrates that anxious individuals display an attentional bias towards threatening 
sources of information, and this effect is less consistent or typically not observed in non-anxious 
individuals. Eysenck and colleagues (Derakshan and Eysenck, 2009; Eysenck, Derakshan, 
Santos, Calvo, 2007) propose attentional control theory (ACT). This theory states that individual 
differences in trait anxiety are embedded in higher order cognitive function. High anxious 
individuals have an inclination to suppress their behavior in risk taking conditions. However, 
behavioral suppression is compensated by increased attention to external stimuli. Therefore 
anxiety is a bias toward the stimulus driven attention system over a goal directed attention 
system making task irrelevant stimuli become more intrusive than it does in low trait anxious 
individuals. Persons with high anxiety try to control their environment, as much as possible.  
Moreover, their attention to the environment and their own behavior is constantly maintained at a 
higher level. This attentional deficit requires them to recruit additional cognitive resources using 
more neuronal power than should be necessary; thus, leaving fewer resources for other cognitive 
processes. Neurophysiology of attentional control includes the lateral prefrontal cortex and the 
anterior cingulate cortex, particularly in the allocation of attentional resources and executive 
function (Miller & Cohen, 2001). These findings suggest that anxiety interferes with recruitment 






 Likewise, in cognitive psychology, preferential attention to negatively valenced stimuli is 
interpreted as negativity bias (Ito, Larsen, Smith, Cacioppo, 1998). Excessive arousal due to 
trauma or stress may result in permanent brain changes that exacerbate a bias towards the 
expectation of threat. Beck (1976) highlighted how negativity biases are central to the 
development and maintenance of depression and anxiety. Biases towards fear stimuli in 
depression and anxiety have been observed in cognitive tasks that manipulate both nonconscious 
and conscious processing (Bradley Mogg, Millar, White, 1995). Anxious (GAD) and normal 
participants carried out a modified Stroop color-naming task with anxiety- and depression-
related words. Compared with controls, the GAD subgroup showed slower color naming for 
negative than neutral words. In addition, within the anxious group, patients with GAD without 
concurrent depression showed more color-naming interference for anxiety words than neutral 
words than participants with comorbid GAD and depression. The neurocircuitry of negativity 
bias may be associated with anticipation of a fear cue (Carretié, Mercado, Hinojosa, Jose, 
Martin-Loeches, Sotillo, 2004). This unconscious processing of anxiety produces hyperactivation 
in the amygdala, mPFC and AC (Williams & Gordon, 2007). 
 Anxiety is an interesting construct that has derived many theories regarding its 
functionality and physiology.  Regardless of the theoretical background used to explain anxiety, 
millions of people suffer from this disorder.  Illumination on the physiological response to a 
given stressor may facilitate better understanding and lead to more effective treatments for 





Generalized Anxiety Disorder 
 Generalized anxiety disorder is characterized by excessive diffuse anxiety and worry that is 
difficult to control and debilitating to daily life (American Psychology Association, 2000).  
GAD’s listed features in the DSM-IV are muscle tension, trembling, twitching, feeling shaky, 
and muscle aches/soreness. It also includes hypervigilance and hyper arousal comprising of an 
accelerated heart rate, shortness of breath and dizziness. Somatic symptoms such as sweating, 
nausea, diarrhea, and exaggerated startle response characterize it as well. GAD has a prevalence 
rate of 3% in one year and 5% in the lifetime. It frequently occurs with other mood disorders, 
anxiety disorders, and substance abuse disorders (APA, 2000). Different cultures seem to express 
GAD differently; somatic symptoms are more of a focus in some, while cognitive symptoms are 
weighted more heavily in others (APA, 2000).  
 A reduction of cerebral blood flow (CBF) has been found to be a customary characteristic 
of GAD (Mathews & Wilson, 1987; Nutt, 2001).  In negative emotional processing, greater 
amygdala and insula activity was found in GAD compared to controls (Etkin & Wager 2007). 
However, some studies have not found exaggerated amygdala response in GAD (Blair, 2008). 
With regard to prefrontal activity, Monk, Nelson, McClure, Mogg, Bradley, Leibenluft, Blair, 
Chen, Charney, Ernst, Pine, (2006) found greater fMRI BOLD responses in the right 
ventrolateral prefrontal cortex to emotionally adverse stimuli in GAD compared to healthy 
controls. Many of these regions have been implicated in control of the HPA axis.  
Stress Response Systems:  
 Stress responses are related to behavior, cognition, and psychopathology (Fortunato, 
Dribin, Granger, Bus, 2008). Both stress responses evoke a chain of neuroendocrine reactions.  A 
variety of stressful events cause an increase in epinephrine in several brain regions including the 
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hypothalamus, amygdala, and locus coeruleus in a rat model (Tanaka, Yoshida, Emoto, Ishii, 
2000). Another neurotransmitter, serotonin has been shown to be involved in the HPA axis 
(Hanley & Van de Karr, 2003). But the most predictable anxiolytic effects seem to be linked to 
the GABAergic system, specifically in the benzodiazepine receptors (Bailey & Nutt, 2008; 
Hoehn-Saric, 1982). The autonomic nervous system has been shown to play a role in stress 
related disorders such as depression and anxiety (Careny, Freedland, Weith, 2007; Guinjoan, 
Bernabo, Cardinali, 1995; Vaith, Lewis, Linares, Barnes, Raskind, Villacres, Murburg, Ashleigh, 
Castillo, Peskind, 1994; van Veen et al., 2008).  
 Two of the main physiological systems activated by stress are the SAM pathway (which is 
the short term “flight or flight” indicator of stress) and the HPA axis (which is more of a long 
term hormonal measure of stress). The SAM pathway starts with the hypothalamus stimulating 
the adrenal medulla. This begins the autonomic nervous system response by secreting the 
hormone adrenaline. Adrenaline stimulates the sympathetic nervous system (SNS) “fight or 
flight” response which includes decreased digestion, increased sweating blood pressure, and 
innervates the salivary glands. The SAM pathway and the HPA axis, together, play a role in 
homeostasis through catecholamine and glucocorticoid interaction (Engert, Efanov, Duchesne, 
Corbo, Pruessner, 2011).        
SAM Pathway, Alpha-Amylase, and Stress 
 Under activation of the SNS and the SAM pathway, alpha-amylase (alpha-1, 4-alpha-D-
glucan 4-glucanohydrolase) is one of the major protein components produced in saliva, 
accounting for 40-50% of gland produced protein (Zakowski & Bruns, 1985). It is produced via 
alpha and beta adrenergic mechanisms (Nater & Rohleder, 2009) in the epithelial acinar cells of 
the exocrine salivary glands (Baum, 1993). Its main function is the enzymatic digestion of 
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carbohydrates (Baum, 1993), but it is also important for mucosal immunity in the oral cavity, as 
it inhibits the adherence and growth of bacteria (Rohleder & Nater, 2009). Because sAA is 
produced with the saliva, it may be a better salivary marker of stress compared to cortisol. It is an 
active measurement, as opposed to cortisol which is passively transported by saliva (Baum, 
1993).   
 Recently, the use of alpha-amylase (sAA) as an indicator of stress has become widely 
popular (Nater, Rohleder, Gaab, 2005). It is sensitive to physical and psycholological stress 
(DeCaro, 2008; Granger, Kivlighan, el-Sheikh, Gordis, Stroud, 2007; Nater & Rohleder, 2009; 
Strahler, Berndt, Kirschbaum, Rohleder, 2010). In addition, it has been shown to be an accurate 
indicator of autonomic function (Ehlert, Erni, Hebisch, Nater, 2006) and has been shown to 
correlate with  norepinephrine in the blood under exercise and psychosocial stress (Chatterton, 
Vogelsong, Lu, Ellman, Hudgens, 1996). Moreover, it has been shown to be suppressed by beta-
adrenorecepter blockade (van Stergen, Rohleder, Everaerd, Wolf, 2006). It tends to be elevated 
in pathological populations including generalized social anxiety disorder (van Veen et al., 2008), 
schizophrenia (Inagaki et al., 2010), and borderline personality disorder (Nater Chrousos, Kino, 
2010).  
 In a study of the genetics of sAA, correlations were larger for monozygotic than dizygotic 
twins, although both groups had large correlations. Out et al. (2011) concluded that there is 
evidence for one common genetic factor that accounted for 51% of the variance of sAA levels at 
baseline and between 56%and 62% during a stressful baby cry paradigm. It has been shown that 
age has no effect of sAA levels (Aguirre, Levine, Cohen, Tabak, 1987; Salvolini, Mazzanti, 
Martarelli, Di Gorgio, Fratto, Curatola, 1999), but more recent evidence has suggested that basal 
sAA levels increase with age (Strahler, Berndt, Kirschbaum, Rohleder, 2010).  
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  Almost every physiological system has some sort of circadian rhythm. Disruptions in this 
biological rhythm have been associated with several psychological and physical disorders 
including renal disease (Kock et al., 2009), depression (Tan et al., 2007), and post traumatic 
stress disorder (Wessa et al., 2006). Both Alpha amylase (sAA) and cortisol follow diurnal 
rhythms. The diurnal pattern of sAA activity decreases sixty-minutes after waking and increases 
at throughout the day (Natar, Rohleder, Schlotz, Ehlert, Kirschbaum, 2007) while cortisol is 
highest in the morning then decreases throughout the day. sAA responds faster to acute 
challenges and has a lower activation threshold than cortisol (Gordis et al., 2006). Few studies 
have compared the differences between sAA and cortisol levels as a function of pathological 
anxiety.  We examined both (diagnostic classification and pathways) in this study. 
HPA Axis and Stress 
Secretion of cortisol, through the HPA axis, is a necessary physiological response to 
emotional and physical stress. It promotes survival in life threatening situations.  Salivary 
cortisol levels are highly positively correlated with serum levels of cortisol (r>.9) (Umeda, 
Hiramatsu, Iwaoka, Shimada, Miura, & Sato, 1981). Salivary cortisol is actually advantageous to 
serum cortisol due to the fact that only free hormone fraction will be determined, removing the 
buffer of other influences such as binding proteins (Foley & Kirschbaum, 2010; Follenius & 
Brandenberger, 1986). Moreover, it is a non-invasive measure, which reduces potential “carry-
over” effects that may be associated with more invasive methods (plasma cortisol). 
 Stimulation of the paraventricular nucleus of the hypothalamus results in activation of 
the HPA axis producing ACTH from the pituitary gland. ACTH stimulates the adrenal cortex 
and produces cortisol, which enables the body to maintain steady supplies of blood sugar. 
Adequate and steady blood sugar levels help a person cope with prolonged exposure to a stressor 
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by ensuring it has enough energy to meet the demand and help the body to return to homeostasis. 
It takes about 30 minutes to peak, although it shows vast variation in latency to peak within 
people (Foley & Kirschbaum, 2010). The PFC, hippocampus, and parahippocampal gyrus have 
been implicated in the modulation of the HPA axis function by acting as a site for 
glucocorticoids to exert negative feedback (Diorio, Viau, & Meaney, 1993; Hurley-Guis & 
Neafsey, 1986; Jahn et al., 2010; Pruessner, Dedovic, Pruessner, Lord, Buss, Collins, Dagher, 
Lupien, 2010; Sapolsky, Romero, Munck,2000).  
Chronic psychological distress can lead to hyperactivity of the HPA axis (Baldwin, 
Cannon, Fischer, Kivisto, 2008; Mantella et al., 2008; O’Brien, Lloyd, McKeith, Gholkar, 
Ferrier, 2006) and increase cortisol activity at these sites. This can cause damage to the 
hippocampal neurons  (Sapolsky et al., 2000), which results in deleterious effects on memory 
and executive functions (Bremner, Vythilingam, Vermetten, Anderson, Newcomer, Charney, 
2004; Li, Cherrier, Tsuang, Petrie, Colasurdo, Craft, Schellenburg, Peskind, Raskind, Wilkinson, 
2006; Lupien, Lecours, Lussier, Schwartz, Nair, Meaney, 1994; Mantella et al., 2008).  
Additionally, aging alters the basal cortisol rhythmicity and possibly diminishes the ability to 
regulate the HPA axis. (Van Cauter, Leproult, Kupfer, 1996; Lupien et al., 1994).  
A relationship has also been found between anxiety and cortisol levels.  For example, 
Vreeburg, Zitman, van Pelt, Derijk, Verhagen, van Dyke, Hoogendijk, Smith, & Penninx (2010) 
conducted a cortisol investigation in populations with and without anxiety disorders. They found 
a significant positive association with all anxiety disorders and morning cortisol. This included 
panic disorder, agoraphobia, major depressive disorder, and generalized anxiety disorder. 
However the largest contributors to the correlation were panic disorder with agoraphobia and 
anxiety disorders comorbid with depression.  However, Vedhara, Miles, Bennett, Plummer, 
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Tallon, Brooks, Gale, Munnoch, Schreiber-Kounine, Fowler, Lightman, Sammon, Rayter, & 
Farndon  (2003)  did not find a significant correlation between stress, anxiety and absolute 
cortisol levels in 54 women attending a diagnostic breast clinic.  However they did find a non-
linear relation between time of day and cortisol levels. More specifically, cortisol levels 
decreased as the day progressed.  Finally, studies show that cortisol levels often do not correlate 
with alpha amylase during stress (Chatterton et al., 1996; Nater & Rohleder, 2009; Schenkels, 
Veerman, Nieuw Amerongen, 2005, Strahler et al., 2010) reaffirming their activity due to two 
different stress systems.   
Objectives: 
van Veen et al. (2008) examined 43 general social anxiety disorder participants regarding 
HPA axis and ANS functioning. They found elevated levels of basal sAA and diurnal sAA, but 
not cortisol in participants with generalized social anxiety. Similarly, Takai et al. (2004) 
examined the effects of a psychosocial stressor and soother on salivary cortisol and sAA levels in 
young adults and compared them to the trait version of the State-Trait Anxiety Inventory (STAI). 
The participants provided samples every three minutes throughout a stressing and/or soothing 
video. sAA levels rose at the start of the stressor and fell to baseline at the end. Cortisol levels 
rose to a lesser extent and remained elevated for a longer period of time than the sAA. Also, sAA 
levels, but not cortisol levels, correlated with the trait version of the STAI. The question remains 
whether there are differences in resting and response conditions in the SAM pathway and HPA 
axis activity in generalized anxiety compared to non-clinical populations. 
To our knowledge, we are the first to examine sAA and cortisol response in a GAD 
population in the same study. The objective of the current study is to examine the 
neuroendocrine measures of stress in non clinical populations compared to a generalized anxiety 
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disorder population using cortisol as a measure of the HPA axis and sAA as a measure of the 
SNS. We will evoke stress in the participants by using a six-minute knee replacement surgery 
video clip. The endocrine measures will then be compared with the Beck Anxiety Inventory 
(BAI), a diagnostic inventory measuring state anxiety, and the Taylor Manifest Anxiety Scale 
(TMAS), a scale measuring trait anxiety.  
Hypothesis  
  We hypothesize that the GAD group will have greater basal cortisol than the non-
clinical group, but there will be no differences between groups for basal sAA 
levels. 
 We hypothesized that baseline cortisol and sAA will be positively related 
irrespective of group. 
 We hypothesized that there will be a greater increase in cortisol and sAA levels 
from pretest to posttest stimulus in the clinical group compared to the normal 
population.  
 We hypothesized that high trait anxiety as measured by the TMAS will be 
associated with higher basal cortisol levels, but not sAA levels.  
 We hypothesized that higher two week state anxiety scores as measured by the 




Section 2: Methods 
Participants   
The study included 46 university students between the ages of 18 and 25 divided 
(M=20.609, SD =1.9262) into two groups of a GAD (n=22; M=20.542, SD =2.1865) and a 
normal population (n=24; M=20.682, SD =1.6442). The sample was 76% female (n=36) and 
83% Caucasian (n=38), 13% African American (n=6), 3% Hispanic (n=2). The GAD participants 
had a diagnosis of GAD as confirmed by the Miniature International Neuropsychiatric Interview 
(M.I.N.I.) or a BAI score of >15. All subjects were recruited from the University of Tennessee 
Knoxville’s Human Participation in Research pool. The students were offered extra credit for 
their participation. All participants completed an Informed Consent document (see appendix) and 
held the right to drop out of the study at any time. 
Materials: 
Miniature International Neuropsychiatric Interview - 
All participants underwent a minimally intrusive standardized clinical interview at the 
start of this study.  The clinical interview took approximately 10 minutes to complete and was 
completed after the first cortisol sample and before the video.  This study used the M.I.N.I., 
which follows DSM-IV-TR (2004) AXIS I diagnostic criteria for relevant clinical interviewing 
process inquiring about current psychopathological diagnosis, present symptoms (i.e., within past 
two-weeks) and life-time history of psychopathological episodes (i.e., initial onset and 






Knee Replacement Surgery Video –  
 The video is a YouTube video showing a knee replacement surgery. It is a six minute 
video clip and was shown on a computer screen in the Biopsychology Laboratory at the 
University of Tennessee. Viewing videos of surgery is a widely used stimulus that activates 
hormonal stress response (Bosch et al., 2003; Takai et al., 2004; Takai, Yamaguchi, Aragaki, 
Eto, Uchihashi, Nishikawa, 2007). 
Beck Anxiety Inventory (BAI) –  
The BAI is a state dependent measure of anxiety (Beck, 1993). Engagement in the BAI 
places the participant in the anxiety-reminiscent context, therefore eliciting a state-dependent 
anxiety response. It is a diagnostic tool; therefore, scores on the BAI are directly related to 
participant symptoms. It is also used to assess clinical treatment. The BAI consists of twenty-one 
questions expressed as common symptoms of anxiety (e.g. numbness and tingling, sweating not 
due to heat, and fear of the worst happening). It is designed for an age range of 17–80 years old. 
Each question has the same set of four possible answer choices, which are arranged in columns 
and are answered by marking the appropriate one with a cross. These are: Not at all (0 points), 
Mildly: It did not bother me much. (1 point), Moderately: It was very unpleasant, but I could 
stand it. (2 points), Severely: I could barely stand it. (3 points). The BAI has a maximum score of 
63.  It is rated such that: 0-7: minimal level of anxiety, 8-15: mild anxiety, 16-25: moderate 
anxiety, 26-63: severe anxiety. The BAI is psychometrically sound as indicated by internal 




Taylor Manifest Anxiety Scale- 
The TMAS is a 50 item scale used as a general indicator of trait anxiety (Taylor, 1953). 
True-false responses are used for each item, and the responses indicating anxiety are summed. 
The scores range from 0 to 50 with higher scores indicating greater trait anxiety. It is up to the 
discretion of the investigator to decide where they fit in the “manifest anxiety” interpretation. 
Items judged by clinicians as being indicative of manifest anxiety were selected from the 
Minnesota Multiphasic Personality Inventory. Correlations of 0.72 and 0.75 were reported 
between the TMAS and Evsenck’s measure of neuroticism in two samples. High correlations of 
0.81 and 0.92 were reported between the TMAS and the psycho-asthenia scale of the MMPI and 
a low of 0.64 with the Beck Depression Inventory. For the original 50-item version, retest 
correlations of 0.89, 0.82, and 0.81 over intervals of three weeks, five months and nine to 17 
months (Taylor, 1953). 
Saliva Sampling- 
Participants were seated and instructed to expectorate into a sanitized 50 mL collection tube once 
per minute over a three minute period (Navazesh, 1993). Once collected, saliva samples were 
centrifuged for ten minutes, alloquated in microtubes (two per sample), and stored at -70 degrees 
Celsius for subsequent analysis. We also obtained medications, time of day, and data relative to 
menstrual cycle for female participants among other variables as indicated by (Kudielka, 
Hellhammer, & Wust, 2009). We asked that participants not smoke, eat, or exercise within an 
hour of sampling (Salimetrics Inc.).  We collected one saliva sample prior to the stressful video, 
and this sample was the baseline for both the cortisol and sAA measures. We collected a second 
sample right after the video which corresponds to the expected  peak of the sAA response and a 
20 
 
third sample 20 minutes after the second sample which corresponds to the expected peak of 30 
minutes for the cortisol response. 
Analyzing sAA- 
Supernatants were analyzed for total sAA concentration using the Salivary Alpha-
Amylase Kit (Salimetrics Inc, PA). This method utilizes a chromagnic substrate, 2-cloro-p-
nitrophenol, linked with maltotriose (Wallenfells et al., 1978) the enzyme action of the sAA on 
this substrate yields 2-chloro-p-ntrophrenal, which can be spectrophotometrically measured at 
405nm. The amount of sAA activity present in the sample is directly proportional to the increase 
in absorbance at 405nm. Assay concentrations are given in opitical density and were converted 
to U/mL and range from 3.1 – 423.1 U/mL. The Assay has been shown to be test-retest reliable 
for high, medium, and low with a coefficient of variation of 2.5%, 6.7%, and 7.2% respectively 
(n=10) (Salimetrics Inc., PA). Samples were divided randomly and equally between two plates. 
Analyzing Cortisol- 
 Supernatants were analyzed for total cortisol concentration using the High Sensitivity 
Salivary Cortisol Enzyme Immunoassay Kit (Salimetrics Inc., PA). The bound cortisol 
peroxidase is measured by the reaction of peroxidase enzyme on the substrate 
tetramathylbenzidine (TMB). Assay concentrations are given in optical density that must be 
converted to μg/dL, and the assay can detect cortisol levels from 0.003 to 3.0 μg/dL. Optical 






 The subjects signed up for a designated time on the University of Tennessee Human 
Participation in Research pool (HPR) and signed an Informed Consent Statement.  We collected 
the first saliva sample from each participant and then administered the (M.I.N.I.). Subjects were 
then seated in front of a computer monitor where they were shown a 6-minute video clip of a 
knee replacement surgery or travel documentary on the Blue Mountains of Australia. The latter 
video acted as a non-stressed control condition. . This provided an appropriate mechanism for 
examining activation or non activation of the HPA axis and SAM pathway. Immediately, after 
the video we collected the second saliva sample and collected the third saliva sample 20 minutes 
after the second. Next, the participants filled out the BAI and TMAS to assess their state and trait 
anxiety levels respectively. It is important to do these after the post cortisol sample to avoid any 
confounds in the stressor. Participants held the right to drop from the study at any time. 
Data Analysis 
 The study design is a 2 x 2 x 2 x 3(Group [GAD vs Control] x Condition [stress vs no 
stress] x Stress Measure [sAA vs Cortisol] x Time [T1, T2, T3]). All data analyses were 
performed in SPSS 19 32-bit statistical mining program. We used an alpha level of .05 for all 
statistical tests. First a data transformation was performed creating difference time series data for 
cortisol and sAA measures which entered the data as cort2-1, cort3-1, sAA 2-1, sAA3-1. In order 
to determine differences between groups and stress conditions, several multivariate generalized 
linear analyses were performed on the dependent measures (physiological and self-report 
variables). The fixed factors were the group (GAD vs Control) and the condition (experimental 
vs control). A bivariate correlation was performed between BAI, TMAS, Cort T1, and sAA T1.  
Means and standard deviation for the study variables are presented in Table 1. 
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Section 3: Results 
Cortisol 
 Figure 1 presents the cortisol results as a function of group, condition, and time.  It 
was hypothesized that basal salivary cortisol levels would be elevated in the GAD group 
compared to the non-clinical group.  The analysis revealed a marginally significant difference 
between groups for baseline cortisol levels [F (1,46) = 2.875, p=.098]. There was a significant 
group by condition interaction [F (1,46) = 4.351, p=.044]. This means that the non-clinical 
(M=.385, SD= .181) and GAD groups (M=.531, SD=.298) had no difference in baseline cortisol, 
but the GAD, stress condition (M=.645, SD=.328) had significantly elevated baseline cortisol 
level before seeing the video (see Figure 3). We hypothesized there would be an increased 
cortisol response in the GAD at T2 (M=.468, SD=.244) and T3 (M=.396, SD=.209) compared to 
the non-clinical group at T2 (M=.605, SD.463) and T3 (M=.540, SD=.540). There were no 
significant differences between groups in the cortisol response for T2 [F (1,46) = .286, p=.596] 
and T3 [F (1,46) = .149, p=.702] (see Table 5). Moreover, there were no significant interactions ( 
p > .05). However, there was a significant difference is cortisol response from T1 to T2 between 
the stress (M=.146, SD=.585) and non- stress conditions (M=-.179, SD=.454), [F (1,46) = 4.519, 
p=.04]. This suggests that the surgical video elicited a greater neuroendocrine stress response 
compared to the control video.  
Correlational data are presented in Table 4. We hypothesized that the BAI would be 
positively associated with baseline cortisol levels. The analysis yielded no significant correlation 
[r (44) = .07, p=.46] between baseline cortisol and the BAI. We hypothesized that trait anxiety, 
as measured by the TMAS, would be positively correlated with baseline salivary cortisol. The 
analysis yielded no significant correlation between the TMAS and baseline cortisol levels [r 
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(1,46) = .185, p = .109]. Finally, we hypothesized a positive correlation between cortisol levels 
and sAA. Contrary to our hypothesis, a significant inverse correlation was found between 
baseline cortisol levels and baseline sAA levels [r (42) = -.26, p=.041]. As baseline cortisol 
levels increased, baseline sAA levels decreased.   
 
Alpha-Amylase 
 Figure 2 presents the sAA results as a function of group, condition, and time.  We 
hypothesized that the GAD group would not have an elevated baseline sAA compared to the 
non-clinical group. The analysis indicated no significant main effect between the non-clinical 
(M=24.480, SD=28.936) and GAD groups (M=17.428, SD=19.964) for baseline sAA levels [F 
(1,44) = .999, p=.324] (see Table 5). We also hypothesized there would be a greater sAA 
response in GAD compared to non-clinical groups. There were no significant differences in the 
increases of sAA levels between the non-clinical group for T2 (M=-.0156, SD=32.816) or T3 
(M=-1.843, SD=35.417) and GAD groups at T2 [(M=4.547, SD=25.585), F (1,44) = .263 
p=.611] or T3 [(M=4.323, SD=28.770), F (1,44) = .508, p=.480]. Also, there was no difference 
for sAA responses for condition at T2 [F (1,44) = .533, p=.470] or T3 [F (1,44)  = 1.650, 
p=.207].   However, there was a marginally significant group by condition interaction for T2 
sAA response [F (1,44) = 3.696, p = .062] but not T3 [F (1,44) = .000, p=1] (See Table 5). This 
suggests that breaking the groups into stress, no-stress subgroups had some effect on the sAA 
response. The non-clinical, non-stress subgroup had a significantly different stress response from 
the other three subgroups. Although it was not significant, the GAD, stress condition (M=12.135, 
SD=33.320) and the GAD, control condition (M=10.233, SD=27.060) both had elevated sAA 
levels T1 to T2 to T3 (see Table 3).  
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We hypothesized that there would be no significant correlation between baseline sAA 
and BAI or TMAS measures. As predicted there was no significant relationship between baseline 
sAA and BAI [r (1,44) = -.111, p = .236] or baseline sAA and TMAS measures [r (1,44) = .-135, 
p = .191]. Neither the BAI nor TMAS showed a relationship with baseline sAA measures.  
 
Anxiety Scales 
There was a significant main effect for the TMAS [F (3,46) = 12.445, p=.000] according 
to group. The GAD group (M=23.864, SD=7.213) showed a significantly higher TMAS score 
than the non-clinical group (M=11.667, SD=5.189). We did not include the Beck because we 
used it as part of our grouping criteria. However, also as predicted, the BAI and TMAS had a 
significant positive correlation [r (44) = .792, p=.000] (see Table 4). The scores of one 





Section 4: Discussion 
The aim of our study was to examine the two stress responses in GAD compared to non-
clinical populations using cortisol and sAA measures. Our hypotheses were partially supported.  
Although the groups did not differ significantly with regard to baseline cortisol levels, it was in 
the hypothesized direction.  Moreover, baseline cortisol levels were inversely related to baseline 
sAA levels.  
Cortisol 
We did not find a significant difference between GAD and non clinical groups for 
baseline cortisol, however it was in the hypothesized direction. This lack of a relationship has 
been found previously by Takahashi et al. (2005) but there are other studies that have also found 
a positive relationship between increased baseline cortisol and pathology (Careny, et al., 2007; 
Guinjoan, et al., 1995; Vaith, et al., 1994).  One reason for our finding may be our 
disproportional amount of females in our GAD group (77%). Highly anxious females have been 
found to have significantly lower cortisol levels than highly anxious males (Takai, Yamaguchi, 
Aragaki, Eto, Uchihashi, Nishikawa, 2007). However, we performed a multivariate general 
linear ANOVA with sex as a covariate that determined that sex did not influence our results. 
Alternatively, our non-significant finding may be due to diagnostic technique.  In our study, the 
anxiety group was determined using the M.I.N.I.  We did not follow-up with other techniques for 
determining GAD.  In addition, it is possible that our GAD group was confounded with other 
disorders because we only controlled for comorbid anxiety disorders. For example, depression 
has been found to be significantly associated with GAD (Kessler et al., 2005). It is also possible 
that our GAD group was not GAD. The BAI may not add the same level of anxious individuals 
as the M.I.N.I. 
26 
 
 We found a significant group by stress condition interaction, which indicates that our 
GAD, stress subgroup had significantly elevated baseline cortisol compared to the other groups. 
This was determined with a tukey’s post hoc test of the means. This suggests that the groups 
were different at the start of the study and could have altered several of the cortisol comparison 
results including the stress-induced cortisol response.  
With regard to the stress manipulation, we used a knee replacement surgery clip.  
Previous studies (Bosch et al., 2003; Takai et al., 2004, Takai et al., 2007) have employed the 
viewing of surgical clips as a method for inducing stress and anxiety. We did find a significant 
increase in salivary cortisol levels for the stress condition.  Regardless of group, individuals 
viewing the knee replacement video displayed greater elevation in salivary cortisol than the 
participants in the no-stress condition. This suggests that our stressor caused a cortisol stress 
response providing evidence that our stressful video was successful eliciting a stress response. 
Behavioral observations supported this conclusion of the knee replacement video as stressful.  
For example, several participants showed eye aversion and fidgeting while viewing the video.  
 
Alpha Amylase 
 With regard to the protein sAA, we found no significant differences between groups on 
baseline measures.  The null hypothesis was supported in our study and is in line with previous 
research regarding basal sAA and GAD (Fisher, Granger, Newman, 2010). We expected this 
result because sAA is a response to arousal as it is correlated with the release of epinephrine. 
Epinephrine is released in response to stress in the ANS.  Although we found that the GAD 
group reported greater trait anxiety compared with the non-clinical control participants, there 
was no significant difference on sAA levels between the groups contrary to Takai et al. (2004).  
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Moreover, sAA did not correlate significantly with any of the self-report measures, yet we found 
a significant inverse relationship between baseline cortisol levels and baseline sAA levels. We 
are unaware of any previous research that has found this result. The inverse relationship may be 
due to our data collection being limited to morning hours. sAA drops to its lowest in the morning 
and cortisol peaks at its highest in the morning hours. The diurnal patterns continue to oppose 
each other throughout the day. Alternatively, Het, Schoofs, Rohleder, and Wolf (2012) found a 
negative correlation between cortisol and negative affect. They also found a positive correlation 
between sAA levels and negative affect. They explained that the negative affect of the stressor is 
associated with sAA levels then cortisol acts as a “mood buffer” later on. While this is not a 
direct inverse relationship it may provide us with insight to our findings. Neither group 
experienced an increase in sAA. Therefore it is possible the GAD group entered the study with 
negative affect due to everyday stressors of university life causing an up regulation of baseline 
cortisol to try to buffer the circular negativity bias associated with anxiety.  
There have been a number of studies that have reported no relationship between sAA and 
cortisol (Chatterton et al., 1996; Fisher, Granger, Newman, 2010; Nater & Rohleder, 2009; 
Schenkels, Veerman, Nieuw Amerongen, 2005, Strahler et al., 2010, van Veen et al., 2008). van 
Veen et al. (2008) did not find significant differences for cortisol levels, but did find significant 
differences between baseline sAA levels and diurnal sAA levels between SAD and control 
groups. They suggested an imbalance in the two stress systems.  It may be that GAD does not 
evoke autonomic arousal at baseline. Fisher, Granger, and Newman, 2010 reported that the 
DSM-IV removed the autonomic activity (e.g. sweating, increased heart rate, etc.) from its 
criteria for generalized anxiety (DSM-IV, 1994) because there was trouble replicating autonomic 
function in a clinical setting. In concordance to this, they found no significant difference between 
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GAD and controls for baseline sAA levels. They sampled 107 participants and divided them 
using the MINI into Control (n=62), GAD (n=21), and GAD comorbid (n=24). They measured 
sAA levels at baseline and post stressful video. They found that the GAD and GAD comorbid 
group act very differently in terms of their sAA response. Of their GAD cormorbid group, 15 
were depressive disorders. They provided evidence that GAD shows diminished physiological 
flexibility and that comorbidity must be taken into account when examining sympathetic arousal 
of anxiety disorders. It is possible that our lack of account for depressive disorders skewed our 
results. In the same way, Fisher & Newman (2013) reported diminished HR responses and 
concluded suppression of adrenergic sympathetic response in GAD. Therefore, it is possible that 
GAD individuals exhibit a diminished SAM pathway response and an over active HPA axis. 
Granted that both the SAM pathway and HPA axis both start in the hypothalamus, it may be that 
in GAD individuals the hypothalamus responds to  minor stressors as “chronic” therefore 
activating HPA axis to acute stress as opposed to the SAM pathway in GAD. Or there may be a 
blocked system that causes a one-way activation path to the HPA axis for all stressors. This 
would consequently deprive the SAM pathway of resources and activation reducing the amount 
of alpha-amylase produced, but increase cortisol. Because our groups did not show a sAA 
response, our data neither supports nor refutes this hypothesis. Future studies should investigate 
this further. It is also possible that general academics or the process of coming in for an 
unfamiliar experiment causes activation of one stress response but not the other. Further studies 
are warranted to understand the relationship between the two stress response systems in GAD. 
   We also hypothesized that the stress manipulation would generate greater levels of sAA 
in the GAD group compared to the non-clinical participants.  This hypothesis was not supported. 
However, Takai et al (2004) reported the use of a stressful video to consequently increase sAA 
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levels, but these levels returned to baseline by the end of the video watching.  They took saliva 
samples throughout the video manipulation.  In our study, saliva samples were collected 
immediately after the 6 minute video viewing and 30 minutes later.  
 
BAI vs TMAS 
We found a significant positive correlation between the state and trait measures of 
anxiety. This was an expected finding and it is consistent with other researchers (Gould et al., 
1984; Hanton et al., 2002). The significant correlation between the BAI and TMAS is interesting 
because they are supposed to measure state and trait anxiety respectively. Our results suggest 





 Some limitations to the study include methodology, choice of stressor, sample size, and 
sample acquisition. First, our sample was a convenience sample. The HPR pool allows for 
students to sign up for studies in exchange for class credit. There may have been a bias of 
students that were drawn to the title of the study due to personal issues.  Likewise, the time 
period for participations was limited to the morning hours.  This may have influenced the type of 
participants for this study.  Also sample size was a limiting factor. It was difficult to find 24 
people with GAD. We therefore included people who qualified as medium anxiety (score >15) 
according to the BAI, which has been used for diagnostic purposes. It was also difficult to find 
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24 people that did not have any underlying anxiety problem. Cleaner group delineation may have 
yielded richer data and a better understanding regarding this subject matter. 
 Part of our study that may have been limiting for us was our choice of stressor. Choosing 
the surgical video was designed to have the participant view something that would make them 
uncomfortable enough to produce a physiological response without having to frighten them or 
produce a specific type of anxiety such as a social situation. In those cases for example, we 
would no longer be measuring GAD; we would be measuring Phobias or Social Anxiety 
Disorder (SAD). This gives us a narrow range of stressor to choose from, but according to our 
data the stressor was effective. It is also possible that the video made some people anxious, 
because they are scared of surgeries. There is also the possibility that the participants entered the 
study nervous and therefore their arousal levels were already elevated.  
Finally, it must be noted that the sAA analysis was amended due to equipment issues.  
The protocol requires that the sAA substrate solution be warmed for 20 minutes to 37º C in plate 
incubator.  This is a kinetic assay and the substrate must be warmed in order to facilitate binding.  
We did not have a plate incubator, but warmed the solution on a hot plate.  We used a 
thermometer to gage the temperature of the solution during this 20 minutes time period.  It is 
plausible that this amended protocol may have influenced our sAA findings.    
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Section 5: Future Directions and Conclusion 
 In the future, this experiment should be replicated with a larger sample, cleaner 
diagnostic groupings, and different types of stressors. This would provide insight into the 
different ways each anxiety disorder differs with respect to physical and psychological stressors 
and the neuroendocrine correlates associated with such an environmental stimulus. Similar to the 
Takahasi et al. (2005), repeated sampling of saliva during the stressor would improve upon the 
sensitivity of the current study. Finally, incorporating a 37º C plate incubator for analyzing sAA 
is also warranted.   
 In conclusion, we found differences in cortisol response between conditions supporting our 
premise that the surgical video was stressful. We found marginal differences in baseline cortisol 
between groups, a marginally significant interaction between groups and condition that suggest 
that the GAD, treatment subgroup had a greater T2 response than the other subgroups. We found 
no significant difference between groups or subgroups that would suggest deviant autonomic 
activation. We also found a negative correlation between baseline sAA and cortisol levels. This 
provides evidence of opposing diurnal patterns between the two stress response systems. And the 
marginally significant effect of baseline cortisol between groups suggests that cortisol may be a 
better determinate of stress in GAD. Finally, there was also a significant difference between 
groups on the TMAS. This may provide evidence for the TMAS to be used clinically as a 
diagnostic tool. 
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 N Mean Std. Deviation 
Age 46 20.609 1.926 
Beck 46 12.174 9.379 
TMAS 46 17.500 8.717 
Cort 1 46 .455 .252 
Cort2  46 .533 .368 
Cort 3 46 .465 .350 
sAA 1  44 20.954 24.825 
sAA 2 44 18.666 26.210 
sAA 3 44 23.466 24.556 
DIFF(Cort2,1) 45 -.005 .547 
DIFF(Cort3,1) 45 -.003 .514 
DIFF(sAA2,1) 43 2.318 29.076 
DIFF(sAA3,1) 43 1.312 31.952 







Non-clinical Group Means 
 Condition Mean N Std. Deviation 
Age 
Stress 20.583 12 2.644 
Non-Stress 20.500 12 1.732 
Total 20.542 24 2.186 
Beck 
Stress 6.000 12 4.285 
Non-Stess 6.000 12 3.437 
Total 6.000 24 3.799 
TMAS 
Stress 11.667 12 6.242 
Non-Stress 11.667 12 4.163 
Total 11.667 24 5.189 
Cort 1 
Stress .350383 12 .210 
Non-Stress .420858 12 .147 
Total .385621 24 .181 
Cort2  
Stress .454908 12 .260 
Non-Stress .481992 12 .237 
Total .468450 24 .244 
Cort 3 
Stress .369783 12 .202 
Non-Stress .422433 12 .220 
Total .396108 24 .209 
sAA 1  
Stress 15.654 11 13.379 
Non-Stress 33.306 11 37.522 
Total 24.480 22 28.936 
sAA 2 
Stress 13.835 11 23.758 
Stress 11.569 11 22.48 
Total 12.702 22 22.602 
sAA 3 
Stress 13.597 11 22.947 
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Non-clinical Group Means 
Condition Mean N Std. Deviation 
Non-Stress 20.723 11 20.415 
Total 17.160 22 21.506 
DIFF(Cort2,1) 
Stress .138 12 .339 
Non-Stress -.112 11 .341 
Total .018 23 .356 
DIFF(Cort3,1) 
Stress .090 12 .295 
Non-Stress -.079 11 .343 
Total .009 23 .323 
DIFF(sAA2,1) 
Stress 12.136 10 33.320 
Non-Stress -11.062 11 29.541 
Total -.015 21 32.816 
DIFF(sAA3,1) 
Stress -8.495 10 42.651 
Non-Stress 4.204 11 28.056 
Total -1.843 21 35.417 
 




GAD Group Means 
 Condition Mean N Std. Deviation 
Age 
Stress 20.333 12 1.497 
Non-Stress 21.100 10 1.792 
Total 20.682 22 1.644 
Beck 
Stress 17.667 12 6.125 
Non-Stress 20.400 10 11.834 
Total 18.909 22 9.033 
TMAS 
Stress 23.417 12 7.573 
Non-Stress 24.400 10 7.121 
Total 23.864 22 7.213 
Cort 1 
Stress .644 12 .328 
Non-Stress .395 10 .197 
Total .531 22 .298 
Cort2  
Stress .778 12 .542 
Non-Stress .397 10 .230 
Total .605 22 .463 
Cort 3 
Stress .715 12 .5384 
Non-Stress .330 10 .179 
Total .540 22 .451 
sAA 1  
Stress 14.978 12 15.139 
Non-Stress 20.368 10 25.144 
Total 17.428 22 19.964 
sAA 2 
Stress 19.789 12 17.102 
Non-Stress 30.438 10 38.603 
Total 24.629 22 28.658 
sAA 3 
Stress 28.645 12 24.489 
Non-Stress 31.127 10 29.506 
54 
 
GAD Group Means 
Condition Mean N Std. Deviation 
Total 29.773 22 26.246 
DIFF(Cort2,1) 
Stress .154 12 .775 
Non-Stress -.252 10 .564 
Total -.030 22 .703 
DIFF(Cort3,1) 
Stress .173 12 .705 
Non-Stress -.244 10 .567 
Total -.016 22 .666 
DIFF(sAA2,1) 
Stress -.191 12 24.428 
Non-Stress 10.233 10 27.060 
Total 4.547 22 25.585 
DIFF(sAA3,1) 
Stress -1.448 12 26.433 
Non-Stress 11.250 10 31.298 
Total 4.323 22 28.770 
 
 




Table of Correlations 
 TMAS Cort 1 sAA T1  
Beck Pearson Correlation .729 .007 -.111 
Sig. (1-tailed) .000* .480 .236 
N 46 46 44 
TMAS Pearson Correlation  .185 -.135 
Sig. (1-tailed)  .109 .191 
N  46 44 
Cort T1 Pearson Correlation   -.265 
Sig. (1-tailed)   .041* 





Tests of Between-Subjects Effects 
Source Dependent Variable 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model TMAS 1616.420
a
 3 538.807 12.628 .000* 
Cort 1 .549
b
 3 .183 3.196 .034* 
sAA 1  2245.176
c
 3 748.392 1.225 .314   
CortT2-T1 1.438
d
 3 .479 1.595 .206 
CortT3-T1 1.200
e
 3 .400 1.498 .230 
sAAT2-T1 3635.488
f
 3 1211.829 1.483 .234 
sAAT3-T1 2133.008
g
 3 711.003 .681 .569 
Intercept TMAS 13486.556 1 13486.556 316.091 .000* 
Cort 1 8.976 1 8.976 156.846 .000* 
sAA 1  19674.803 1 19674.803 32.195 .000* 
CortT2-T1 .001 1 .001 .003 .959 
CortT2-T1 .001 1 .001 .003 .954 
sAAT2-T1 330.158 1 330.158 .404 .529 
sAAT3-T1 81.151 1 81.151 .078 .782 
Group TMAS 1615.633 1 1615.633 37.866 .000* 
Cort 1 .165 1 .165 2.875 .098 
sAA 1  610.375 1 610.375 .999 .324 
CortT2-T1 .086 1 .086 .286 .596 
CortT3-T1 .040 1 .040 .149 .702 
sAAT2-T1 214.940 1 214.940 .263 .611 
sAAT3-T1 530.673 1 530.673 .508 .480 
Condition TMAS 3.916 1 3.916 .092 .764 
Cort 1 .100 1 .100 1.747 .194 
sAA 1  1240.066 1 1240.066 2.029 .162 
CortT2-T1 1.358 1 1.358 4.519 .040* 
CortT3-T1 1.056 1 1.056 3.955 .054 
sAAT2-T1 435.988 1 435.988 .533 .470 
sAAT3-T1 1723.723 1 1723.723 1.650 .207 
Group * Condition TMAS 1.527 1 1.527 .036 .851 
Cort 1 .249 1 .249 4.351 .044* 
sAA 1  309.502 1 309.502 .506 .481 
CortT2-T1 .028 1 .028 .092 .763 
CortT3-T1 .115 1 .115 .430 .516 
sAAT2-T1 3020.872 1 3020.872 3.696 .062 
sAAT3-T1 6.599E-7 1 6.599E-7 .000 1.000 
Error TMAS 1663.998 39 42.667   
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Tests of Between-Subjects Effects 
Dependent Variable 
Type III Sum of 
Squares df Mean Square F Sig. 
Cort 1 2.232 39 .057   
sAA 1  23833.556 39 611.117   
CortT2-T1 11.720 39 .301   
CortT3-T1 10.416 39 .267   
sAAT2-T1 31873.556 39 817.271   
sAAT3-T1 40746.316 39 1044.777   
Total TMAS 17033.000 43    
Cort 1 12.121 43    
sAA 1  45820.348 43    
CortT2-T1 13.158 43    
CortT3-T1 11.616 43    
sAAT2-T1 35740.265 43    
sAAT3-T1 42953.342 43    
Corrected Total TMAS 3280.419 42    
Cort 1 2.780 42    
sAA 1  26078.732 42    
CortT2-T1 13.158 42    
CortT3-T1 11.616 42    
sAAT2-T1 35509.045 42    
sAAT3-T1 42879.325 42    
a. R Squared = .493 (Adjusted R Squared = .454) 
b. R Squared = .197 (Adjusted R Squared = .136) 
c. R Squared = .086 (Adjusted R Squared = .016) 
d. R Squared = .109 (Adjusted R Squared = .041) 
e. R Squared = .103 (Adjusted R Squared = .034) 
f. R Squared = .102 (Adjusted R Squared = .033) 
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